Diego Braguglia

Diego Braguglia is a Managing Partner at VI Partners AG, a leading Swiss venture capital firm focused on supporting promising start-up companies with capital and networks since 2003. In addition to this role, Braguglia serves as a Board Member Observer at Sibylla Biotech and holds board positions at AB2 Bio Ltd., MedLumics, iOnctura, Xeltis, and MerLion Pharmaceuticals. Braguglia has also been a Board Member at Covalys Biosciences and served as Président du Jury for Prix Strategis since 2017. With a PhD from ISREC and a Dipl. Phil. II in Molecular Genetics from the Biozentrum at the University of Basel, Braguglia brings a strong academic background to the venture capital and biotechnology sectors.